Back to Savant Capital, LLC Savant Capital, LLC

CORTCORT

Showing 8 of 10 quarters

Position history for Savant Capital, LLCSavant Capital, LLC's holdings in Corcept Therapeutics Incorporated

Yes. Savant Capital holds 6,935 shares of CORT (Corcept Therapeutics), worth $604,827, as of its Q2 2026 13F filing. It reduced the position by 315 shares (-4.3%) from Q1 2026. Savant Capital has held CORT since Q1 2024, across 10 quarterly 13F filings.

Current Value

$604,827

Current Shares

6,935

Total Value Change

-$245,245

Total Shares Change

-11,433

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6,935
-4.3%
$604,8270.0%$86.95
0
2026-Q1
Increased
7,250
+19.8%
$292,2490.0%$40.31
28
2025-Q4
Decreased
6,050
-6.1%
$210,5400.0%$34.80
0
2025-Q3
Increased
6,445
+7.0%
$535,6440.0%$83.11
26
2025-Q2
Decreased
6,025
-0.1%
$442,2350.0%$73.40
0
2025-Q1
Decreased
6,028
-67.2%
$688,5190.0%$114.22
0
2024-Q4
Increased
18,389
+0.1%
$926,6220.0%$50.39
25
2024-Q3
Increased
18,368
+0.2%
$850,0720.0%$46.28
25

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used